Clinical Trial Update: To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing liraglutide with glimepiride to assess HbA1c reduction in adults with Type 2 diabetes; the study was terminated with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• Victoza (Liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED | Results posted: 2010-03-12